PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “BLADDER NEOPLASMS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 163 records · Page 9Linked to original sources
PubMed1991

[Endogenous risk factors for bladder neoplasms in women].

A case-control study was performed to evaluate hormonal status in 154 female patients with bladder cancer and 213 healthy women. Cancer patients were characterized by shorter reproductive period and miscarriage, absence of gestation, endometrial and breast cancer and ovarian cysts in the past history. Evaluation of tryptophan metabolism in 131 male and 111 female patients with bladder cancer showed the occurrence of a carcinogenic metabolite--3-oxyanthranilic acid--in the urine to be higher in women. Blood hormone levels were measured in 55 female patients and 49 healthy women by radioimmunoassay. Decreased levels of progesterone and estradiol as well as of hormones potentiating their production (folitropin and lutropin) were the most frequent hormonal disorders encountered.

3-Hydroxyanthranilic Acid↗
PubMed1983

[Embolization of the inferior mesenteric artery in hemorrhagic bladder neoplasms after failure of hypogastric arteries embolization].

The authors report 3 cases of revascularisation through the inferior mesenteric artery of bladder tumors which had previously been treated by transcatheter occlusion of both hypogastric arteries because hemorrhage. New uncomplicated embolizations of the inferior mesenteric artery are performed in 2 cases and recurrency of the bleeding was stopped.

Acrylic Resins↗
PubMed1997

[Alternatives to the cystoscopic control of bladder neoplasms].

OBJECTIVE: Cystoscopy is the most sensitive technique for the detection of bladder tumor recurrence, but is the least accepted by the patient. In our Service, 25% of cystoscopies are poorly tolerated. Our experience with alternatives to cystoscopy is described. METHODS: Using cystoscopy as the gold standard, we analyzed the diagnostic yield of cytology, vesicorenal US and the combination of vesicorenal US and cytology. The techniques were compared for sensitivity vs 1-specificity. RESULTS: The sensitivity of the alternative techniques was limited. At best it was 0.81 when US and cytology were used in combination. The specificity was low and the incidence of false negatives was 7.3%. Similarly, the diagnostic yield was better when US and cytology were used in combination (sensitivity vs 1-specificity = 0.77). CONCLUSIONS: No technique, alone or in combination, can replace cystoscopy. However, alternate use of combined US and cytology with cystoscopy is efficient in the follow-up of bladder tumors and can reduce the number of cystoscopies. The delay in the diagnosis of recurrence probably has not negative negative influence on the history of the disease.

Cystoscopy↗